Salt composition containing calcium magnesium acetate and sodium silicate
CA 2110809 C · Owner: Chemopharm Laboratory, Inc. · Inventors: Simper, Jack L.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The inventive composition contains salt calcium magnesium acetate (CMA) and , sodium silicate and may optionally contain, sodium ferrocyanide diatomaceous earth, and/or other materials. The composition is useful for facilitating the melting and removal of snow and ice, and is stable and non-corrosive. The inclusion of both CMA and sodium silicate in the salt composition provides better corrosion resistance than can be obtained by the inclusion of comparable quantities of either CMA or sodium silicate alone. The inventive salt composition is considerably less expensive to manufacture than CMA-containing salt compositions which provide comparable corrosion resistance.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 5, 1992 and granted September 7, 1999. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended March 5, 2012.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 5, 2014.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.